The Lancet: November 01, 2013
The Lancet in conversation with - A podcast by The Lancet Group - Fridays
Categories:
Clive Ballard discusses the efficacy of pimavanserin for treatment of Parkinson's disease psychosis.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv